
Jennifer Sue Pitrak Mcdonald
Examiner (ID: 5815, Phone: (571)270-3061 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1635, 3792, 1674, 3796, 1609 |
| Total Applications | 600 |
| Issued Applications | 220 |
| Pending Applications | 26 |
| Abandoned Applications | 355 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19246411
[patent_doc_number] => 20240197395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => ABLATION SYSTEM WITH AUTOMATED ABLATION ENERGY ELEMENT
[patent_app_type] => utility
[patent_app_number] => 18/393371
[patent_app_country] => US
[patent_app_date] => 2023-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18393371
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/393371 | ABLATION SYSTEM WITH AUTOMATED ABLATION ENERGY ELEMENT | Dec 20, 2023 | Abandoned |
Array
(
[id] => 18986646
[patent_doc_number] => 20240058615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => METHODS AND SYSTEMS FOR REDUCING INTERFERENCE IN STIMULATION TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/460963
[patent_app_country] => US
[patent_app_date] => 2023-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15847
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18460963
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/460963 | METHODS AND SYSTEMS FOR REDUCING INTERFERENCE IN STIMULATION TREATMENT | Sep 4, 2023 | Abandoned |
Array
(
[id] => 18418814
[patent_doc_number] => 20230173274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => HIGH FREQUENCY ELECTROMAGNETIC STIMULATION FOR MODULATING CELLS, INCLUDING SPONTANEOUSLY ACTIVE AND QUIESCENT CELLS, AND ASSOCIATED SYSTEMS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/889633
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17889633
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/889633 | HIGH FREQUENCY ELECTROMAGNETIC STIMULATION FOR MODULATING CELLS, INCLUDING SPONTANEOUSLY ACTIVE AND QUIESCENT CELLS, AND ASSOCIATED SYSTEMS AND METHODS | Aug 16, 2022 | Abandoned |
Array
(
[id] => 17752550
[patent_doc_number] => 20220230755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Systems and Methods for Cognitive Diagnostics for Neurological Disorders: Parkinson's Disease and Comorbid Depression
[patent_app_type] => utility
[patent_app_number] => 17/716464
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716464
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/716464 | Systems and Methods for Cognitive Diagnostics for Neurological Disorders: Parkinson's Disease and Comorbid Depression | Apr 7, 2022 | Abandoned |
Array
(
[id] => 18182320
[patent_doc_number] => 20230043049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => MOBILE CONFIGURABLE LIGHT THERAPY DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/397487
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17397487
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/397487 | MOBILE CONFIGURABLE LIGHT THERAPY DEVICE | Aug 8, 2021 | Abandoned |
Array
(
[id] => 18034907
[patent_doc_number] => 20220379122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => Manufacturing Method for an Implantable Medical Device
[patent_app_type] => utility
[patent_app_number] => 17/775448
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17775448
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/775448 | Manufacturing Method for an Implantable Medical Device | Dec 8, 2020 | Abandoned |
Array
(
[id] => 17686108
[patent_doc_number] => 20220193400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => NEURAL INTERFACE
[patent_app_type] => utility
[patent_app_number] => 17/594622
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594622
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594622 | NEURAL INTERFACE | Apr 23, 2020 | Abandoned |
Array
(
[id] => 17655687
[patent_doc_number] => 20220176152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHOD AND SYSTEM FOR IMPROVING LIGHT INTAKE, LIGHT EXPOSURE, AND LIFESTYLE MANAGEMENT OF A USER
[patent_app_type] => utility
[patent_app_number] => 17/598931
[patent_app_country] => US
[patent_app_date] => 2020-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598931
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598931 | METHOD AND SYSTEM FOR IMPROVING LIGHT INTAKE, LIGHT EXPOSURE, AND LIFESTYLE MANAGEMENT OF A USER | Mar 31, 2020 | Abandoned |
Array
(
[id] => 16267572
[patent_doc_number] => 20200269059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => APPARATUS, SYSTEMS, AND METHODS TO IMPROVE ATRIAL FIBRILLATION OUTCOMES INVOLVING THE LEFT ATRIAL APPENDAGE
[patent_app_type] => utility
[patent_app_number] => 16/796895
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16796895
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/796895 | APPARATUS, SYSTEMS, AND METHODS TO IMPROVE ATRIAL FIBRILLATION OUTCOMES INVOLVING THE LEFT ATRIAL APPENDAGE | Feb 19, 2020 | Pending |
Array
(
[id] => 15927099
[patent_doc_number] => 20200155183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => ARTICULATING SURGICAL TOOLS AND TOOL SHEATHS, AND METHODS OF DEPLOYING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/454606
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454606
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/454606 | ARTICULATING SURGICAL TOOLS AND TOOL SHEATHS, AND METHODS OF DEPLOYING THE SAME | Jun 26, 2019 | Abandoned |
Array
(
[id] => 15356001
[patent_doc_number] => 10526603
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-01-07
[patent_title] => Double-stranded ribonucleic acid capable of suppressing expression of complement C5
[patent_app_type] => utility
[patent_app_number] => 16/354916
[patent_app_country] => US
[patent_app_date] => 2019-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14006
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16354916
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/354916 | Double-stranded ribonucleic acid capable of suppressing expression of complement C5 | Mar 14, 2019 | Issued |
Array
(
[id] => 14808431
[patent_doc_number] => 20190270825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => METHODS AND COMPOSITIONS FOR REDUCING CARDIAC DAMAGE AND OTHER CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/255521
[patent_app_country] => US
[patent_app_date] => 2019-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16255521
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/255521 | Methods and compositions for reducing cardiac damage and other conditions | Jan 22, 2019 | Issued |
Array
(
[id] => 14043969
[patent_doc_number] => 20190078091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => ANTISENS OLIGONUCLEOTIDES FOR THE TREATMENT OF LEBER CONGENITAL AMAUROSIS
[patent_app_type] => utility
[patent_app_number] => 16/197865
[patent_app_country] => US
[patent_app_date] => 2018-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16197865
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/197865 | Antisense oligonucleotides for the treatment of Leber congenital amaurosis | Nov 20, 2018 | Issued |
Array
(
[id] => 14930651
[patent_doc_number] => 20190300963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => MIRNA EXPRESSION SIGNATURE IN THE CLASSIFICATION OF THYROID TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/192221
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34039
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16192221
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/192221 | MIRNA EXPRESSION SIGNATURE IN THE CLASSIFICATION OF THYROID TUMORS | Nov 14, 2018 | Abandoned |
Array
(
[id] => 15832465
[patent_doc_number] => 20200131514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => METHOD FOR ISOLATING CROSS-REACTIVE APTAMER AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/174764
[patent_app_country] => US
[patent_app_date] => 2018-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16174764
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/174764 | Method for isolating cross-reactive aptamer and use thereof | Oct 29, 2018 | Issued |
Array
(
[id] => 15816975
[patent_doc_number] => 10633654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Modified RNAi polynucleotides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/153424
[patent_app_country] => US
[patent_app_date] => 2018-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 37
[patent_no_of_words] => 29448
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16153424
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/153424 | Modified RNAi polynucleotides and uses thereof | Oct 4, 2018 | Issued |
Array
(
[id] => 13790895
[patent_doc_number] => 20190008986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/139091
[patent_app_country] => US
[patent_app_date] => 2018-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 225611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16139091
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/139091 | Oligonucleotide compositions and methods thereof | Sep 22, 2018 | Issued |
Array
(
[id] => 13622855
[patent_doc_number] => 20180362979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => THERAPEUTIC AND DIAGNOSTIC MOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/056393
[patent_app_country] => US
[patent_app_date] => 2018-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16056393
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/056393 | THERAPEUTIC AND DIAGNOSTIC MOLECULES | Aug 5, 2018 | Abandoned |
Array
(
[id] => 15634889
[patent_doc_number] => 10590423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-17
[patent_title] => Treatment of age-related macular degeneration using RNA complexes that target MyD88 or TLR3
[patent_app_type] => utility
[patent_app_number] => 16/042833
[patent_app_country] => US
[patent_app_date] => 2018-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13328
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16042833
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/042833 | Treatment of age-related macular degeneration using RNA complexes that target MyD88 or TLR3 | Jul 22, 2018 | Issued |
Array
(
[id] => 15912981
[patent_doc_number] => 10653712
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => High purity RNA compositions and methods for preparation thereof
[patent_app_type] => utility
[patent_app_number] => 16/001786
[patent_app_country] => US
[patent_app_date] => 2018-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 72
[patent_figures_cnt] => 52
[patent_no_of_words] => 38211
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16001786
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/001786 | High purity RNA compositions and methods for preparation thereof | Jun 5, 2018 | Issued |